Moderna’s stock is falling. Goldman Sachs says it’s no longer a buy.
Shares of vaccine maker Moderna fell Wednesday as Goldman Sachs lowered its rating after the biotech’s second cut to product revenue guidance in six months.
The Goldman Sachs Group, Inc. (GS): Among the Large-Cap Stocks Insiders Are Buying Recently
We recently compiled a list of the 10 Large-Cap Stocks Insiders Are Buying Recently. In this article, we are going to take a look at where The Goldman Sachs Group, Inc. (NYSE:GS) stands against the other large-cap stocks.
Last Minute Thought: Goldman Sachs Chimes In on Tesla Stock Ahead of Earnings
Tesla (NASDAQ:TSLA) will be under the Street’s microscope today with the EV giant slated to release 4Q24 results after the close. Investors
Why Goldman Sachs says investors should buy the dip in U.S. tech stocks
Monday’s trillion-dollar stock-market wipeout will be remembered as an opportunity to scoop up shares of some of the most valuable U.S. companies at a discount, according to a team of equity strategists at Goldman Sachs Group.
Which Is a Better Investment, The Goldman Sachs Group, Inc. or Blue Owl Capital Inc. Stock?
Learn more about whether The Goldman Sachs Group, Inc. or Blue Owl Capital Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Goldman Sachs Is Firing On All Cylinders (Technical Analysis)
Goldman Sachs stock is not overvalued as growth in revenue and EPS is impressive. Click here to find out why I believe GS is a buy currently.
Goldman Sachs maintains Microsoft stock Buy rating, $500 target
Goldman Sachs reiterated its Buy rating and $500.00 price target for Microsoft Corporation (NASDAQ:MSFT), following the company's mixed financial results for the second quarter of fiscal year 2025. The investment firm pointed to the ongoing investor concerns over the growth pace of Microsoft's Azure cloud services,
Moderna stock drops as Goldman Sachs cuts rating
Moderna (NASDAQ:MRNA) shares about 3% ahead of Wednesday market open after Goldman Sachs (NYSE:GS) cut its rating on the stock to Neutral from Buy.
24/7 Wall St. on MSN1h
Goldman Sachs Top Stock Picks With 10% and More Upside Pay Huge Dividends
The artificial intelligence rally led by the so-called Magnificent 7 over the past two years has been remarkable if you owned ...
Why Goldman Sachs says the DeepSeek plunge doesn't point to the start of a big stock market correction
"In our view this is a correction and not the start of a sustained bear market," Goldman Sachs said. DeepSeek sparked a $1 ...
Money Morning1d
OXY Stock Alert: Wall Street Targets Falling
Occidental Petroleum ( OXY) Fell to its lowest level in more than six weeks following a downgrade from Goldman Sachs. The ...
HEDGE FLOW Stock hedge funds post big one-day drop in DeepSeek rout, say Goldman data
Hedge fund stock-pickers lost billions of dollars on Monday in a rout in global technology shares sparked by the emergence of ...
Moderna Stock Is Sliding Wednesday: Here's Why
Moderna Inc (NASDAQ:MRNA) shares are trading lower Wednesday after Goldman Sachs downgraded the stock. Here's what you need ...
The bears never stood a chance — this month. But Goldman strategist says he’ll turn ‘tactical bear’ after Valentine’s.
Between you-only-live-once retail traders, big corporates buying back their stock and retirement allocation demand, the bears ...
Insider trades: Verizon, Goldman Sachs among notable names this week
A weekly summary of insider trading highlighting a few notable buying and selling by investors, directors and executives. The trades have taken place between January 27, 2025 and January 31, 2025. • ...
Colgate-Palmolive Remains One Of The Highest-Quality Names Despite Tough End-Market Backdrop: Goldman Sachs
Goldman Sachs analyst Bonnie Herzog reiterated a Buy rating on the shares of Colgate-Palmolive Co (NYSE:CL) with a price forecast of $106. CL reported fourth-quarter earnings per share of $0.91, ...